Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule-Reference-Cited by-同舟云学术

Induction of HIV Immunity in the Genital Tract After Intranasal Delivery of a MVA Vector: Enhanced Immunogenicity After DNA Prime-Modified Vaccinia Virus Ankara Boost Immunization Schedule

Published:2004-05-05 Issue:10 Volume:172 Page:6209-6220
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Gherardi M. Magdalena,Pérez-Jiménez Eva,Nájera José Luis,Esteban Mariano

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference80 articles.

1. Innate and adaptive mucosal immunity in protection against HIV infection

2. Gastrointestinal Tract as a Major Site of CD4 + T Cell Depletion and Viral Replication in SIV Infection

3. Vaccines and mucosal immunisation

4. Vaccination Strategies for Mucosal Immune Responses

5. Recent advances in mucosal vaccines and adjuvants

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques;Nature Communications;2023-08-08

2. Factors Limiting the Translatability of Rodent Model–Based Intranasal Vaccine Research to Humans;AAPS PharmSciTech;2022-07-12

3. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection;Proceedings of the National Academy of Sciences;2022-06-09

4. Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis: In Vivo Evaluation in Mice;Vaccines;2021-06-06

5. MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease;2021-01-01